Finance

Lists
Why is MAP up 2.86%?
Dive Deeper
MAP:ASX
Microba Life Sciences Ltd
A$0.036
+2.86%
(+0.00100) 1D
Nov 13, 10:02:22 AM GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for MAP...
Open
A$0.04
High
A$0.04
Low
A$0.04
Mkt. cap
23.40M
Avg. vol.
209.21K
Volume
82.64K
52-wk high
A$0.10
52-wk low
A$0.03
EPS
-A$0.03
Shares outstanding
742.74M
Open
A$0.04
High
A$0.04
Low
A$0.04
Mkt. cap
23.40M
Avg. vol.
209.21K
Volume
82.64K
52-wk high
A$0.10
52-wk low
A$0.03
EPS
-A$0.03
Shares outstanding
742.74M
News stories
From web sources and news partners
About Microba Life Sciences Ltd
CEO-
Employees-
Founded2017
Headquarters-
SectorHealth Care
IndustryHealth care provider
Websitemicroba.com
Last report
Jul 16, 2026
Fiscal period
Q4 2026
- / -
Revenue / Est. (AUD)
3.72M / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.66M
3.66M
3.72M
3.72M
Cost of goods sold
1.98M
1.98M
1.88M
1.88M
Cost of revenue
1.98M
1.98M
1.88M
1.88M
Research and development expenses
142.04K
142.04K
66.49K
66.49K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.06M
5.06M
4.71M
4.71M
Operating expense
7.13M
7.13M
6.54M
6.54M
Total operating expenses
9.11M
9.11M
8.42M
8.42M
Operating income
-5.45M
-5.45M
-4.70M
-4.70M
Other non operating income
658.46K
658.46K
115.51K
115.51K
EBT including unusual items
-5.40M
-5.40M
-5.09M
-5.09M
EBT excluding unusual items
-5.03M
-5.03M
-5.06M
-5.06M
Income tax expense
-125.26K
-125.26K
-6.04K
-6.04K
Effective tax rate
2.32%
2.32%
0.12%
0.12%
Other operating expenses
828.78K
828.78K
652.54K
652.54K
Net income
-5.28M
-5.28M
-5.08M
-5.08M
Net profit margin
-144.21%
-144.21%
-136.65%
-136.65%
Earnings per share
-
-
-
-
Interest and investment income
105.25K
105.25K
52.55K
52.55K
Interest expense
-44.59K
-44.59K
-74.69K
-74.69K
Net interest expenses
60.66K
60.66K
-22.14K
-22.14K
Depreciation and amortization charges
1.10M
1.10M
1.10M
1.10M
EBITDA
-4.70M
-4.70M
-4.62M
-4.62M
Gain or loss from assets sale
-
-
48.64K
48.64K
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps